Biomarker testing service by LGC
Manufacturer LGC | Available Worldwide
LGC's expert biomarker teams support non-clinical and clinical biomarker method development, validation and sample analysis. LGC's capabilities span from measuring single to multiple analyte profiles, such as those employed to monitor cytokine storms.
.jpg.ashx?width=85&height=85)
Biomarker testing service
.jpg)
LGC have a wealth of experience in detection and quantitation of biomarkers in a wide variety of matrices.
More than 200 dedicated scientists work in one the world’s largest bioanalytical facilities with a broad range of analytical platform.
LGC's biomarker services can be adapted to your specific requirements:
- Assay development
- Validation
- Quantification
- Capacity
- Methods and instrumentation
LGC have extensive experience with a range of biomarkers, including those linked to:
- Target engagement
- Coagulation cascade
- Diabetes
- GI disorders
- Inflammatory diseases
- Neurological disorders
- Oncology
- Respiratory diseases
- Endocrinology
- Renal disease/damage
- Stress management
LGC have a range of analytical platforms for LGC's biomarker methodologies, using both ligand binding assays, flow cytometry and mass spectrometry, in a multitude of matrix types:
- Blood/serum/plasma
- Peripheral blood cells
- BALF
- Sputum
- Bone marrow
- Solid tumours
- FFPE
- CSF
- Saliva
- Synovial fluid
- Urine
- Sweat
- Tears
- Breast milk
Analytical platforms
- Quanterix® HD-X analyser
- Sciex TripleTOF® 6600 LC-MS
- Gyrolab® xP
- LC-MS
- MSD®
- Luminex MAGPIX®
- Envision
- Beckman Coulter CytoFLEX
- Randox Daytona+
Product Overview
.jpg.ashx?width=100&height=100&bgcolor=white)